Clinical trial
Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study
NCT03977428 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study
- Lead sponsor
- Wuhan Asia Heart Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2019
- Completion date
- June 30, 2023
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.